XBI experienced an approximate $452.2M outflow, a 5.8% week-over-week decline in shares outstanding. The move reflects investor redemptions and a modest risk-off repositioning in biotech exposure—material for the ETF and underlying names but unlikely to drive broader market moves.
XBI experienced an approximate $452.2M outflow, a 5.8% week-over-week decline in shares outstanding. The move reflects investor redemptions and a modest risk-off repositioning in biotech exposure—material for the ETF and underlying names but unlikely to drive broader market moves.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
